Seres Therapeutics (MCRB) Asset Utilization Ratio (2016 - 2025)
Seres Therapeutics (MCRB) has disclosed Asset Utilization Ratio for 10 consecutive years, with 0.01 as the latest value for Q4 2025.
- Quarterly Asset Utilization Ratio changed N/A to 0.01 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.01 through Dec 2025, changed N/A year-over-year, with the annual reading at 0.01 for FY2025, N/A changed from the prior year.
- Asset Utilization Ratio hit 0.01 in Q4 2025 for Seres Therapeutics, up from 0.0 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.46 in Q2 2022 to a low of 0.5 in Q3 2024.
- Historically, Asset Utilization Ratio has averaged 0.1 across 5 years, with a median of 0.03 in 2021.
- Biggest five-year swings in Asset Utilization Ratio: soared 1650.29% in 2022 and later crashed 252.24% in 2024.
- Year by year, Asset Utilization Ratio stood at 0.38 in 2021, then crashed by 94.37% to 0.02 in 2022, then tumbled by 86.68% to 0.0 in 2023, then plummeted by 17651.07% to 0.5 in 2024, then soared by 101.11% to 0.01 in 2025.
- Business Quant data shows Asset Utilization Ratio for MCRB at 0.01 in Q4 2025, 0.0 in Q3 2025, and 0.5 in Q3 2024.